
4 stocks to watch on Friday: PM, PFE, MSTR, HIMS
HIMS HERS PROBED BY US FTC OVER CANCELLATION PRACTICES
7.31BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4330001060
CUSIP
433000106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
2.15
Book Value
1.93
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.09
Wall Street Target Price
29.23
EPS Estimate Current Year
-0.13
EPS Estimate Next Year
0.62
EPS Estimate Current Quarter
0.0343
EPS Estimate Next Quarter
0.0956
Most Recent Quarter
-
Revenue TTM
2,369,731,072
Gross Profit TTM
1,727,975,936
EBITDA
83,416,000
Profit Margin
-0.56%
Return On Assets TTM
0.60%
Return On Equity TTM
-2.66%
Revenue Per Share TTM
10.46
Qtly Revenue Growth YOY
3.80%
Diluted Eps TTM
-0.09
Qtly Earnings Growth YOY
-17.40%
Trailing PE
0.00
Forward PE
58
Price Sales TTM
3.0855
Price Book MRQ
16.3879
Enterprise Value Revenue
3
Enterprise Value EBITDA
204
228.55
3.91%74.83
2.99%36.14
2.21%17.55
0.57%35.89
0.00%43.32
-3.53%89.00
-1.06%9.93
-1.00%166.40
-0.83%33.29
-0.27%